These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27092905)

  • 21. Allergen-specific immunotherapy.
    Niederberger V
    Immunol Lett; 2009 Feb; 122(2):131-3. PubMed ID: 19100771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy - risk/benefit in food allergy.
    Kostadinova AI; Willemsen LE; Knippels LM; Garssen J
    Pediatr Allergy Immunol; 2013 Nov; 24(7):633-44. PubMed ID: 24112425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the use of allergen immunotherapy. Canadian Society of Allergy and Clinical Immunology.
    CMAJ; 1995 May; 152(9):1413-9. PubMed ID: 7728690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
    Caminati M; Dama AR; Djuric I; Montagni M; Schiappoli M; Ridolo E; Senna G; Canonica GW
    Expert Rev Clin Immunol; 2015 Feb; 11(2):233-45. PubMed ID: 25484197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.
    Bukantz SC; Bagg AS; Lockey RF
    Clin Allergy Immunol; 2008; 21():455-68. PubMed ID: 18828523
    [No Abstract]   [Full Text] [Related]  

  • 28. Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report.
    Burks AW; Calderon MA; Casale T; Cox L; Demoly P; Jutel M; Nelson H; Akdis CA
    J Allergy Clin Immunol; 2013 May; 131(5):1288-96.e3. PubMed ID: 23498595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.
    Cox L; Larenas-Linnemann D; Lockey RF; Passalacqua G
    J Allergy Clin Immunol; 2010 Mar; 125(3):569-74, 574.e1-574.e7. PubMed ID: 20144472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergy immunotherapy safety: location matters!
    Cox L; Aaronson D; Casale TB; Honsinger R; Weber R
    J Allergy Clin Immunol Pract; 2013; 1(5):455-7. PubMed ID: 24565616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
    Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
    Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One century of allergen-specific immunotherapy for respiratory allergy.
    Incorvaia C; Frati F
    Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Better documentation through standardized forms: what progress have we made since the 1800s?
    Cox L
    Allergy Asthma Proc; 2004; 25(6):407-22. PubMed ID: 15709452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of rush immunotherapy to multiple aeroallergens in an adult population.
    Harvey SM; Laurie S; Hilton K; Khan DA
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):414-9. PubMed ID: 15104192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current status of allergen-specific immunotherapy on perennial allergic rhinitis].
    Okano M
    Arerugi; 2008 Feb; 57(2):79-85. PubMed ID: 18349581
    [No Abstract]   [Full Text] [Related]  

  • 36. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
    Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.
    Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D
    Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chapter 3: Allergen immunotherapy: definition, indication, and reactions.
    Georgy MS; Saltoun CA
    Allergy Asthma Proc; 2012; 33 Suppl 1():9-11. PubMed ID: 22794676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral Immunotherapy for Peanut Allergy.
    Anagnostou K; Clark A
    Annu Rev Med; 2016; 67():375-85. PubMed ID: 26332004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.